JP Morgan Chase
OM icon

JP Morgan Chase’s Outset Medical OM Stock Holding History

JP Morgan Chase’s Portfolio OM Stock Details OM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$365K Sell
100,977
-8,399
-8% -$34.4K ﹤0.01% 5197
2025
Q4 		$406K Sell
109,376
-6,930
-6% -$59.4K ﹤0.01% 5161
2025
Q3 		$1.64M Buy
116,306
+107,854
+1,276% +$1.68M ﹤0.01% 4228
2025
Q2 		$162K Buy
8,452
+7,344
+663% +$115K ﹤0.01% 5350
2025
Q1 		$12.3K Buy
1,108
+731
+194% +$8.71K ﹤0.01% 6256
2024
Q4 		$6.29K Sell
377
-683
-64% -$8.52K ﹤0.01% 6474
2024
Q3 		$10.8K Sell
1,060
-203,851
-99% -$6.06M ﹤0.01% 6356
2024
Q2 		$11.8M Sell
204,911
-2,736
-1% -$134K ﹤0.01% 2303
2024
Q1 		$6.91M Sell
207,647
-123,100
-37% -$6.23M ﹤0.01% 2806
2023
Q4 		$26.8M Sell
330,747
-9,614
-3% -$782K ﹤0.01% 1612
2023
Q3 		$55.5M Buy
340,361
+16,378
+5% +$3.87M 0.01% 1070
2023
Q2 		$106M Sell
323,983
-5,285
-2% -$1.61M 0.01% 796
2023
Q1 		$90.9M Buy
329,268
+28,171
+9% +$10.3M 0.01% 828
2022
Q4 		$117M Sell
301,097
-35,233
-10% -$9.94M 0.02% 715
2022
Q3 		$80.4M Sell
336,330
-9,765
-3% -$2.61M 0.01% 811
2022
Q2 		$77.1M Buy
346,095
+142,680
+70% +$61.4M 0.01% 857
2022
Q1 		$139M Buy
203,415
+6,959
+4% +$4.19M 0.02% 701
2021
Q4 		$136M Buy
196,456
+7,082
+4% +$5.24M 0.02% 739
2021
Q3 		$140M Buy
189,374
+45,866
+32% +$31.3M 0.02% 710
2021
Q2 		$108M Buy
143,508
+87,125
+155% +$66.6M 0.01% 866
2021
Q1 		$46M Buy
56,383
+501
+0.9% +$387K 0.01% 1198
2020
Q4 		$47.6M Buy
55,882
+33,740
+152% +$26M 0.01% 1097
2020
Q3 		$16.5M Buy
+22,142
New +$18.2M ﹤0.01% 1625

Other funds holding OM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

JP Morgan Chase's OM Position: Q1 2026 in Review

JP Morgan Chase reduced its Outset Medical (OM) stake by 7.7% in Q1 2026, selling an estimated $34.4K and leaving 100,977 shares worth $365K. The position accounts for ﹤0.01% of the portfolio, ranked #5197.

JP Morgan Chase first reported a position in OM in Q3 2020 and has held it in 23 quarters since. The position peaked at $140M in Q3 2021. 99 funds tracked by Wall St. Rank hold OM as of Q1 2026.

  • JP Morgan Chase held 100,977 shares of Outset Medical worth $365K as of Q1 2026.
  • JP Morgan Chase sold 8,399 Outset Medical shares in Q1 2026, an estimated $34.4K.
  • Outset Medical made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #5197 holding.
  • JP Morgan Chase first reported a position in Outset Medical in Q3 2020 and has held it in 23 quarters since.
  • JP Morgan Chase's Outset Medical position peaked at $140M in Q3 2021.
  • 99 funds tracked by Wall St. Rank held Outset Medical as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.